SCHEMBL4854239

SCHEMBL4854239

COc1ccc(/C=C/C(=O)c2cc(-c3ccccc3Cl)ccc2OCCN(C)C)c(F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 3/20 0.46
ABCG2 Q9UNQ0 2/20 0.46
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
ATM Q13315 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TNFRSF1A P19438 2/20 0.41
NPC1 O15118 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TUBB4A P04350 1/20 0.39
TUBB P07437 1/20 0.39
TUBA3C P0DPH7 1/20 0.39
TUBA1B P68363 1/20 0.39
TUBA4A P68366 1/20 0.39
TUBB4B P68371 1/20 0.39
TUBB3 Q13509 1/20 0.39
TUBB2A Q13885 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4848047 1.00 SLC6A9 (0.46) SLC6A9ABCG2MAPTKDM4ELMNA
SCHEMBL4848064 0.92 MAPT (0.45) SLC6A9MAPTKDM4ELMNAGAA
SCHEMBL4851264 0.92 MAPT (0.45) SLC6A9MAPTKDM4ELMNAGAA
SCHEMBL4852348 0.91 SLC6A9 (0.45) SLC6A9MAPTLMNAGAAATM
SCHEMBL4848486 0.91 SLC6A9 (0.45) SLC6A9MAPTLMNAGAAATM
SCHEMBL4848052 0.91 ABCG2 (0.48) SLC6A9ABCG2MAPTKDM4ELMNA
SCHEMBL4857394 0.89 SLC6A9 (0.46) SLC6A9MAPTLMNAGAAATM
SCHEMBL4854827 0.89 SLC6A9 (0.46) SLC6A9MAPTLMNAGAAATM
SCHEMBL4854487 0.89 SLC6A9 (0.46) SLC6A9MAPTLMNAGAAATM
SCHEMBL4854864 0.89 SLC6A9 (0.46) SLC6A9MAPTLMNAGAAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed